Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Lynwood › NPI 1114547114
Hospital

Prime Healthcare Services - ST Francis LLC

Prime Healthcare Services - ST Francis LLC was paid $27.65M by Medicaid between Aug 2020 and Dec 2024, across 263 billing codes. Its largest line is 0450, Emergency room services — 15% of everything it billed.

33Billing provider infoPRIME HEALTHCARE SERVICES - ST FRANCIS LLC
LYNWOOD, CA 90262
33aNPI1114547114assigned 04/20/2020
28Total paid$27.65M
24GClaims998,041
24DCodes billed263
24AFirst – last monthAug 2020 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#96 of 410
Median peer was paid$6.90M
This provider vs. median4.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202038,320$1.05M
2021189,358$7.25M
2022248,638$8.23M
2023281,512$6.20M
2024incomplete240,213$4.93M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 15% 90,793 80,704 $4.10M
0121 12% 571 543 $3.19M
0214 7.6% 437 418 $2.11M
Z7502 3.7% 27,310 26,871 $1.03M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.4% 5,313 5,162 $932K
0122 3.2% 545 536 $885K
70450 Computed tomography, head or brain; without contrast material 3.1% 8,490 8,237 $850K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.7% 16,601 15,005 $749K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.4% 2,090 1,985 $661K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.1% 25,910 24,140 $583K
80053 Comprehensive metabolic panel 2.1% 55,328 51,664 $569K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.8% 24,959 22,136 $511K
251 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.8% 9,628 $504K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.6% 64,652 $442K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1.4% 12,543 $375K
72125 Computed tomography, cervical spine; without contrast material 1.2% 2,884 $332K
93976 1.1% 1,804 $301K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.0% 14,495 $287K
96361 Intravenous infusion, hydration; each additional hour <1% 8,797 $269K
99284 Emergency room visit (serious) <1% 2,059 $269K
99199 Unlisted special service, procedure or report <1% 7,729 $262K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,805 $261K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 3,601 $250K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 4,527 $236K
0171 Inj, epinephrine (belcher) <1% 555 $223K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,372 $221K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 6,089 $218K
Z7610 <1% 18,114 $213K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,400 $201K
0270 <1% 26,282 $200K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,043 $199K
71046 Radiologic examination, chest; 2 views <1% 11,077 $195K
71045 Radiologic examination, chest; single view <1% 15,346 $190K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,102 $178K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,569 $166K
96375 Therapeutic injection; each additional sequential IV push <1% 5,359 $161K
84484 <1% 18,673 $159K
0250 <1% 47,547 $156K
0300 <1% 4,663 $155K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 2,350 $155K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,544 $142K
99283 Emergency room visit (moderate) <1% 2,024 $140K
Z9725 <1% 3,217 $138K
76801 <1% 3,240 $134K
71275 Computed tomographic angiography, chest, with contrast material <1% 821 $129K
93971 <1% 1,286 $127K
81025 <1% 22,258 $124K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 21,521 $121K
0761 <1% 4,503 $120K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,220 $115K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 15,578 $114K
83690 <1% 17,364 $103K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,175 $97K
87086 Culture, bacterial; quantitative colony count, urine <1% 15,120 $95K
83880 <1% 3,879 $92K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,332 $88K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,074 $86K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,076 $86K
J7030 Infusion, normal saline solution , 1000 cc <1% 11,739 $82K
81001 <1% 28,536 $80K
J1953 Injection, levetiracetam, 10 mg <1% 649 $77K
76830 Ultrasound, transvaginal <1% 1,349 $77K
90715 <1% 2,063 $67K
84702 <1% 6,501 $67K
99152 <1% 1,413 $59K
70486 <1% 542 $58K
80048 Basic metabolic panel (calcium, ionized) <1% 6,934 $54K
76819 Fetal biophysical profile; without non-stress testing <1% 1,426 $53K
76770 <1% 837 $53K
87040 <1% 6,081 $53K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,078 $50K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,872 $49K
73030 <1% 2,319 $48K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 622 $47K
73610 <1% 2,007 $45K
73562 <1% 2,241 $43K
93970 <1% 272 $42K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 685 $42K
73130 <1% 1,869 $41K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,516 $40K
73630 <1% 1,840 $39K
0360 <1% 1,076 $39K
83605 <1% 4,224 $37K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,973 $36K
0510 <1% 1,057 $34K
0301 <1% 2,795 $30K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 956 $30K
59025 Fetal non-stress test <1% 1,618 $30K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,535 $30K
87420 <1% 5,422 $30K
73564 <1% 1,106 $29K
0272 <1% 9,789 $28K
85730 <1% 5,781 $28K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,341 $26K
72131 <1% 241 $26K
73110 <1% 1,256 $26K
73502 <1% 1,026 $25K
87186 <1% 3,380 $24K
0682 <1% 461 $23K
0636 <1% 6,632 $23K
81003 <1% 10,659 $22K
77300 <1% 54 $22K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,540 $22K
72100 <1% 793 $21K
85610 <1% 6,308 $20K
99213 Doctor's office visit, returning patient (routine) <1% 825 $20K
73590 <1% 1,052 $19K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 485 $19K
J3490 Unclassified drugs <1% 7,072 $19K
76818 <1% 1,188 $19K
0001A <1% 491 $19K
76870 <1% 426 $18K
77336 <1% 325 $18K
84443 Thyroid stimulating hormone (TSH) <1% 1,382 $18K
86901 <1% 6,391 $17K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 27 $16K
86900 <1% 6,366 $15K
36415 Collection of venous blood by venipuncture <1% 26,927 $15K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,736 $15K
85379 <1% 1,661 $13K
86850 <1% 3,067 $13K
0760 <1% 1,754 $13K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 44 $13K
76775 <1% 344 $12K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 185 $12K
73090 <1% 706 $12K
0002A <1% 287 $11K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,375 $11K
77290 <1% 60 $11K
73080 <1% 449 $10K
87088 <1% 1,825 $10K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,272 $10K
0160 <1% 257 $9K
99203 Doctor's office visit, new patient (routine) <1% 229 $9K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,127 $9K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,251 $9K
J2060 Injection, lorazepam, 2 mg <1% 1,749 $9K
82962 <1% 3,647 $9K
99221 <1% 284 $8K
0710 <1% 936 $8K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,652 $8K
74018 <1% 541 $8K
0762 <1% 105 $7K
86141 <1% 828 $7K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,092 $7K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,307 $7K
J2704 Injection, propofol, 10 mg <1% 763 $7K
P9016 Red blood cells, leukocytes reduced, each unit <1% 44 $7K
83735 <1% 1,330 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,390 $7K
77417 <1% 220 $6K
85027 <1% 1,119 $6K
J1815 Injection, insulin, per 5 units <1% 697 $6K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 113 $5K
87210 <1% 1,525 $5K
87081 <1% 982 $5K
0305 <1% 2,137 $4K
73070 <1% 288 $4K
99204 Doctor's office visit, new patient (more involved) <1% 117 $4K
82550 <1% 760 $4K
0258 <1% 1,753 $4K
82947 <1% 1,006 $4K
73560 <1% 255 $4K
84439 <1% 626 $4K
0410 <1% 211 $4K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 224 $4K
76820 <1% 249 $4K
0460 <1% 187 $4K
73552 <1% 226 $4K
J1170 Injection, hydromorphone, up to 4 mg <1% 544 $4K
96376 <1% 269 $3K
A4649 Surgical supply; miscellaneous <1% 3,145 $3K
Q0181 Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 473 $3K
87077 <1% 548 $3K
73140 <1% 272 $3K
0170 <1% 45 $3K
73060 <1% 198 $3K
99153 Mod sedat endo service >5yrs <1% 258 $3K
85018 <1% 1,495 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 287 $3K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 179 $3K
12001 <1% 190 $3K
0370 <1% 694 $3K
82140 <1% 265 $3K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 201 $3K
86703 <1% 252 $3K
0271 <1% 5,840 $3K
85007 <1% 736 $2K
99070 <1% 970 $2K
J1630 Injection, haloperidol, up to 5 mg <1% 411 $2K
J7050 Infusion, normal saline solution, 250 cc <1% 287 $2K
77334 <1% 12 $2K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 28 $2K
86592 <1% 462 $2K
70498 <1% 12 $2K
80076 <1% 227 $2K
12011 <1% 56 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 352 $2K
A4615 Cannula, nasal <1% 447 $1K
82247 <1% 278 $1K
85384 <1% 173 $1K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 30 $1K
84100 <1% 320 $1K
29125 <1% 248 $1K
99214 Doctor's office visit, returning patient (more involved) <1% 55 $1K
81002 <1% 464 $1K
84550 <1% 276 $1K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 26 $1K
85396 <1% 66 $1K
S0164 Injection, pantoprazole sodium, 40 mg <1% 100 $974.15
77280 <1% 14 $967.94
J0360 Injection, hydralazine hcl, up to 20 mg <1% 126 $798.47
72170 <1% 57 $753.37
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 214 $697.30
0306 <1% 1,871 $691.60
G0379 Direct admission of patient for hospital observation care <1% 29 $630.64
0391 <1% 26 $612.18
82248 <1% 137 $572.46
84112 <1% 80 $519.61
0324 <1% 614 $513.23
86140 <1% 150 $507.91
J3475 Injection, magnesium sulfate, per 500 mg <1% 40 $496.86
73600 <1% 27 $489.89
87070 <1% 55 $468.57
86923 <1% 17 $458.74
J0780 Injection, prochlorperazine, up to 10 mg <1% 65 $378.64
82565 <1% 84 $344.46
20610 <1% 16 $268.36
76857 <1% 12 $262.30
71101 <1% 12 $245.23
36416 <1% 296 $213.60
29515 <1% 28 $196.79
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 49 $190.56
87205 <1% 66 $164.57
29130 <1% 13 $148.40
0302 <1% 1,522 $132.89
12002 <1% 12 $122.52
84520 <1% 26 $102.64
0420 <1% 159 $83.54
83036 Hemoglobin; glycosylated (A1C) <1% 15 $79.49
J1940 Injection, furosemide, up to 20 mg <1% 17 $77.15
94799 <1% 19 $69.18
82010 <1% 13 $56.67
0470 <1% 573 $55.94
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 12 $54.01
0307 <1% 1,235 $50.96
0260 <1% 144 $42.37
A4657 Syringe, with or without needle, each <1% 101 $10.98
0730 0% 603 $0.00
0312 0% 328 $0.00
0402 0% 747 $0.00
0278 0% 12 $0.00
0351 0% 65 $0.00
0361 0% 92 $0.00
0489 0% 56 $0.00
0320 0% 125 $0.00
0481 0% 54 $0.00
91300 0% 29 $0.00
0720 0% 319 $0.00
0371 0% 38 $0.00
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session 0% 138 $0.00
0352 0% 277 $0.00
76377 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDOAN, CHRISTOPHER (MANAGING ASSOCIATE GENERAL COUNSEL)
Same official

Other billing entities under DOAN, CHRISTOPHER

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.